Iovance Biotherapeutics (NasdaqGM:IOVA) FY Conference Transcript

Iovance Biotherapeutics (NasdaqGM:IOVA) FY Conference September 09, 2025 11:00 AM ET Company ParticipantsIgor Bilinsky - COOOperatorCOO at Iovance Biotherapeutics, a biotechnology company developing and manufacturing T-cell-based immunotherapies for solid and liquid cancers. With that, Igor, the floor is yours.Igor BilinskyMorning, everyone. Thanks for having us. I'll be making forward-looking statements as part of this presentation and refer to our filings for the SEC for full disclosure of risks and uncer ...